search
Back to results

Effectiveness of Vestibular Rehabilitation for Improving Health Status in Patients With Fibromyalgia

Primary Purpose

Fibromyalgia, Vestibular Disease, Postural Balance

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Vestibular Rehabilitation Exercises
Conventional Rehabilitation exercises
Sponsored by
University of Jaén
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Fibromyalgia focused on measuring Fibromyalgia, Vestibular Disease, Postural Balance, Vestibular Rehabilitation

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Aged 18-70 years,
  • Diagnostic for fibromyalgia as described by the 2016 American College of Rheumatology (ACR)

Exclusion Criteria:

  • Cognitive impairment impacting ability to fill out the scales and questionnaires.
  • Musculoskeletal surgical intervention in the preceding 6 months and/or acute traumatic pathology to the inferior limb(s).
  • Musculoskeletal disease with deformity of the inferior limbs.
  • Diagnosed with vestibular, visual and/or auditory pathology.
  • Neurologic illness that could be the cause of a balance disorder.

Sites / Locations

  • University os Jaén

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

Vestibular Rehabilitation Exercises

Conventional Rehabilitation exercises

Arm Description

Vestibular Rehabilitation Exercises focused on eye stabilization and Vestibulo-Oculo Reflex (VOR). Two sessions/week supervised by researcher (40 min) and conducting exercises at home 2 times/day, 5 days/week. (15-20 min)

Conventional rehabilitation exercises: stretching and walking. Two sessions/week supervised by researcher (40 min) and conducting exercises at home 2 times/day, 5 days/week. (15-20 min)

Outcomes

Primary Outcome Measures

FIQ (Fibromyalgia Impact Questionnaire)
Evaluates the impact of fibromyalgia on the patient's quality of life.The total score of the FIQ is from 0 to 100. A higher score means a greater impact of the disease on the patient.
FIQ (Fibromyalgia Impact Questionnaire)
Evaluates the impact of fibromyalgia on the patient's quality of life.The total score of the FIQ is from 0 to 100. A higher score means a greater impact of the disease on the patient.
FIQ (Fibromyalgia Impact Questionnaire)
Evaluates the impact of fibromyalgia on the patient's quality of life.The total score of the FIQ is from 0 to 100. A higher score means a greater impact of the disease on the patient.
ABC-16 (Activities-specific Balance Confidence scale-16 items)
Evaluates the balance confidence in performing activities of daily living. The total score of the ABC-16 is from 0% to 100%, with higher values associated with higher balance confidence.
ABC-16 (Activities-specific Balance Confidence scale-16 items)
Evaluates the balance confidence in performing activities of daily living. The total score of the ABC-16 is from 0% to 100%, with higher values associated with higher balance confidence.
ABC-16 (Activities-specific Balance Confidence scale-16 items)
Evaluates the balance confidence in performing activities of daily living. The total score of the ABC-16 is from 0% to 100%, with higher values associated with higher balance confidence.
DHI (Dizziness Handicap Inventory)
Evaluates the level of disability related to the impact of dizziness on daily function and quality of life. The total score of the DHI is from 0 to100 points. A higher score indicates a greater degree of disability due to the vertiginous symptoms.
DHI (Dizziness Handicap Inventory)
Evaluates the level of disability related to the impact of dizziness on daily function and quality of life. The total score of the DHI is from 0 to100 points. A higher score indicates a greater degree of disability due to the vertiginous symptoms.
DHI (Dizziness Handicap Inventory)
Evaluates the level of disability related to the impact of dizziness on daily function and quality of life. The total score of the DHI is from 0 to100 points. A higher score indicates a greater degree of disability due to the vertiginous symptoms.

Secondary Outcome Measures

CSI (Central Sensitization Inventory)
Evaluates a wide range of somatic and emotional symptoms common to central sensitization syndromes (CSS). The total score of the CSI from 0 to 100. Higher scores indicate greater severity of symptoms.
CSI (Central Sensitization Inventory)
Evaluates a wide range of somatic and emotional symptoms common to central sensitization syndromes (CSS). The total score of the CSI from 0 to 100. Higher scores indicate greater severity of symptoms.
CSI (Central Sensitization Inventory)
Evaluates a wide range of somatic and emotional symptoms common to central sensitization syndromes (CSS). The total score of the CSI from 0 to 100. Higher scores indicate greater severity of symptoms.
PCS (Pain Catastrophizing Scale)
Evaluates the patient's catastrophic thoughts. The total score of the PCS from 0 to 52. Higher scores indicate a greater presence of catastrophic thoughts.
PCS (Pain Catastrophizing Scale)
Evaluates the patient's catastrophic thoughts. The total score of the PCS from 0 to 52. Higher scores indicate a greater presence of catastrophic thoughts.
PCS (Pain Catastrophizing Scale)
Evaluates the patient's catastrophic thoughts. The total score of the PCS from 0 to 52. Higher scores indicate a greater presence of catastrophic thoughts.
TSK (Tampa Scale for Kinesiophobia)
Evaluates fear of movement to injury. The total score of the TSK from 11 to 44 points. Higher scores indicate a greater fear of movement.
TSK (Tampa Scale for Kinesiophobia)
Evaluates fear of movement to injury. The total score of the TSK from 11 to 44 points. Higher scores indicate a greater fear of movement.
TSK (Tampa Scale for Kinesiophobia)
Evaluates fear of movement to injury. The total score of the TSK from 11 to 44 points. Higher scores indicate a greater fear of movement.
VAS-pain (Visual Analogue Scale)
Evaluates the pain on a numerical scale from 0 to 10. Higher scores indicate more pain
VAS-pain (Visual Analogue Scale)
Evaluates the pain on a numerical scale from 0 to 10. Higher scores indicate more pain
VAS-pain (Visual Analogue Scale)
Evaluates the pain on a numerical scale from 0 to 10. Higher scores indicate more pain
SF-12 (12-Item Short Form Survey)
Evaluates the impact of health on an individual's everyday life. Used as a quality of life measure.
SF-12 (12-Item Short Form Survey)
Evaluates the impact of health on an individual's everyday life. Used as a quality of life measure.
SF-12 (12-Item Short Form Survey)
Evaluates the impact of health on an individual's everyday life. Used as a quality of life measure.
FES-I (Falls Efficacy Scale-International)
Evaluates the fear of falling. The total score of the FES-I from 16 to 64 points. Higher scores indicate greater fear of falling.
FES-I (Falls Efficacy Scale-International)
Evaluates the fear of falling. The total score of the FES-I from 16 to 64 points. Higher scores indicate greater fear of falling.
FES-I (Falls Efficacy Scale-International)
Evaluates the fear of falling. The total score of the FES-I from 16 to 64 points. Higher scores indicate greater fear of falling.
FSS (Fatigue Severity Scale)
Evaluates severity of fatigue. Higher scores indicate a greater severity of fatigue
FSS (Fatigue Severity Scale)
Evaluates severity of fatigue. Higher scores indicate a greater severity of fatigue
FSS (Fatigue Severity Scale)
Evaluates severity of fatigue. Higher scores indicate a greater severity of fatigue
20-item JAEN screening tool
Evaluates balance and neuromotor function in patients with fibromyalgia. Thd total scale of the Jaen-Screening Tools, from 0 to 80 points. A higher score indicates a greater degree of balance disorder.
20-item JAEN screening tool
Evaluates balance and neuromotor function in patients with fibromyalgia. Thd total scale of the Jaen-Screening Tools, from 0 to 80 points. A higher score indicates a greater degree of balance disorder.
20-item JAEN screening tool
Evaluates balance and neuromotor function in patients with fibromyalgia. Thd total scale of the Jaen-Screening Tools, from 0 to 80 points. A higher score indicates a greater degree of balance disorder.
SVV (Subjective Visual Vertical)
Evaluates the perception of verticality, measured using the Subjective Visual Vertical (SVV) test using a virtual reality device.
SVV (Subjective Visual Vertical)
Evaluates the perception of verticality, measured using the Subjective Visual Vertical (SVV) test using a virtual reality device.
SVV (Subjective Visual Vertical)
Evaluates the perception of verticality, measured using the Subjective Visual Vertical (SVV) test using a virtual reality device.
Stabilometric Platform
Instrument composed of resistive pressure sensors, used to measure the static or postural balance. The test was performed under both eyes-open and eyes-closed conditions.
Stabilometric Platform
Instrument composed of resistive pressure sensors, used to measure the static or postural balance. The test was performed under both eyes-open and eyes-closed conditions.
Stabilometric Platform
Instrument composed of resistive pressure sensors, used to measure the static or postural balance. The test was performed under both eyes-open and eyes-closed conditions.
Therapeutic Adherence at home
It assesses adherence to home treatment through a weekly record diary, where patients must record the number of times a day they perform the prescribed exercises, with a range of 0 to 80. Higher scores indicate greater adherence to home treatment. A score of 80 indicates 100% adherence.
Satisfaction level
Evaluates the level of satisfaction using a Likert scale, with five response options, from "very dissatisfied" to "very satisfied". The total score of 0-24. A high score indicates greater satisfaction
GRC (Global Change Rating Scales)
Assesses whether the patient's health status has improved or deteriorated after the treatment received, with ten response options ranging from "the worst it could be" to "the best it could be"

Full Information

First Posted
January 24, 2022
Last Updated
October 31, 2022
Sponsor
University of Jaén
search

1. Study Identification

Unique Protocol Identification Number
NCT05300529
Brief Title
Effectiveness of Vestibular Rehabilitation for Improving Health Status in Patients With Fibromyalgia
Official Title
Effectiveness of Vestibular Rehabilitation for Improving Health Status in Patients With Fibromyalgia. Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Completed
Study Start Date
June 1, 2021 (Actual)
Primary Completion Date
December 20, 2021 (Actual)
Study Completion Date
April 1, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Jaén

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The purpose of this study is to analyze the effectiveness of Vestibular Rehabilitation for improving balance and quality of life of patients with Fibromyalgia Syndrome (SFM). Recruited subjects will be randomly assigned to an experimental group or control group (placebo). The experimental group will receive a standard Vestibular Rehabilitation program focused on eye stabilization and Vestibulo-Ocular Reflex (VOR) gain with the aim of improving motor and sensory strategies, while the control group will carry out a conventional rehabilitation program that will not include sensory strategy training. The frequency of treatment for both groups will be twice/week, along with daily performing (2 times/day, 5 days/week) of exercises at home. The total duration will be 8 weeks. The outcome measure are: disease impact (FIQ), perceived vertigo (DHI), and confidence in balance (ABC), at pre-treatment, post-treatment, one month follow-up and three months follow-up.
Detailed Description
Fibromyalgia Syndrome (SFM) affects approximately 0.5 - 5% of the global population with ambiguity in diagnosis, physiopathology uncertainty and complex treatment. Recent studies have shown frequent episodes of postural instability in SFM patients. This balance affectation seems to correlate with disturbances of quality of life, pain, impact of the disease, daily life activities and increased risk of falls. However, there is still controversy over the exact mechanism that explains this nonspecific balance disorder. Despite this preliminary finding of a possible visual and vestibular disorder, there are not known studies justifying the alteration of vestibular functions present in Fibromyalgia. Also, the are not certainty that Vestibular Rehabilitation (VR) provides short- and medium-term benefits. Derived from the deficiencies observed in the revised literature, we propose to analyze the effectiveness of a Vestibular Rehabilitation program improving the balance and quality of life of people with Fibromyalgia Syndrome (SFM). Therefore, a randomized, simple blind, two-group parallel controlled clinical trial has been designed to assess the effectiveness of Vestibular Rehabilitation treatment focused on eye stabilization exercises. Subjects will be recruited from the Jaén Fibromyalgia Association (AFIXA) and randomly assigned to an experimental group or control group (placebo). Subjects who are diagnosed with SFM and between 18 and 70 years of age will be selected. The experimental group will receive a standard Vestibular Rehabilitation program focused on the stabilization of the eye and gain of the Vestibulo-Oculo Reflex (VOR), while in the control group a conventional rehabilitation program will be carried out without visual stimulation. The frequency of treatment for both groups will be twice/week, along with daily exercises at home (2 times/day). The total duration will be 8 weeks. Measurements will be made in pretreatment, aftertreatment and one month follow-up and three months follow-up.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fibromyalgia, Vestibular Disease, Postural Balance, Vestibular Rehabilitation
Keywords
Fibromyalgia, Vestibular Disease, Postural Balance, Vestibular Rehabilitation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
35 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Vestibular Rehabilitation Exercises
Arm Type
Experimental
Arm Description
Vestibular Rehabilitation Exercises focused on eye stabilization and Vestibulo-Oculo Reflex (VOR). Two sessions/week supervised by researcher (40 min) and conducting exercises at home 2 times/day, 5 days/week. (15-20 min)
Arm Title
Conventional Rehabilitation exercises
Arm Type
Sham Comparator
Arm Description
Conventional rehabilitation exercises: stretching and walking. Two sessions/week supervised by researcher (40 min) and conducting exercises at home 2 times/day, 5 days/week. (15-20 min)
Intervention Type
Other
Intervention Name(s)
Vestibular Rehabilitation Exercises
Intervention Description
The Vestibular Rehabilitation program focuses on stabilizing the gaze and gaining the Vestibular Ocular Reflex (VOR). The general mechanisms of recovery from vestibular injuries are vestibular adaptation and replacement exercises, which are designed to improve gaze stability and the interaction between sight and the vestibular system during head movements. The exercises will be carried out progressively according to the tolerance of the patient, varying the stimulus in intensity and frequency.
Intervention Type
Other
Intervention Name(s)
Conventional Rehabilitation exercises
Intervention Description
The conventional rehabilitation program in which exercises are performed to improve joint range, flexibility, and gait. It will always be done with the eyes open, on a firm surface and will not include training in sensory strategies
Primary Outcome Measure Information:
Title
FIQ (Fibromyalgia Impact Questionnaire)
Description
Evaluates the impact of fibromyalgia on the patient's quality of life.The total score of the FIQ is from 0 to 100. A higher score means a greater impact of the disease on the patient.
Time Frame
Baseline
Title
FIQ (Fibromyalgia Impact Questionnaire)
Description
Evaluates the impact of fibromyalgia on the patient's quality of life.The total score of the FIQ is from 0 to 100. A higher score means a greater impact of the disease on the patient.
Time Frame
at eight weeks
Title
FIQ (Fibromyalgia Impact Questionnaire)
Description
Evaluates the impact of fibromyalgia on the patient's quality of life.The total score of the FIQ is from 0 to 100. A higher score means a greater impact of the disease on the patient.
Time Frame
at twelve weeks
Title
ABC-16 (Activities-specific Balance Confidence scale-16 items)
Description
Evaluates the balance confidence in performing activities of daily living. The total score of the ABC-16 is from 0% to 100%, with higher values associated with higher balance confidence.
Time Frame
Baseline
Title
ABC-16 (Activities-specific Balance Confidence scale-16 items)
Description
Evaluates the balance confidence in performing activities of daily living. The total score of the ABC-16 is from 0% to 100%, with higher values associated with higher balance confidence.
Time Frame
at eight weeks
Title
ABC-16 (Activities-specific Balance Confidence scale-16 items)
Description
Evaluates the balance confidence in performing activities of daily living. The total score of the ABC-16 is from 0% to 100%, with higher values associated with higher balance confidence.
Time Frame
at twelve weeks
Title
DHI (Dizziness Handicap Inventory)
Description
Evaluates the level of disability related to the impact of dizziness on daily function and quality of life. The total score of the DHI is from 0 to100 points. A higher score indicates a greater degree of disability due to the vertiginous symptoms.
Time Frame
Baseline
Title
DHI (Dizziness Handicap Inventory)
Description
Evaluates the level of disability related to the impact of dizziness on daily function and quality of life. The total score of the DHI is from 0 to100 points. A higher score indicates a greater degree of disability due to the vertiginous symptoms.
Time Frame
at eight weeks
Title
DHI (Dizziness Handicap Inventory)
Description
Evaluates the level of disability related to the impact of dizziness on daily function and quality of life. The total score of the DHI is from 0 to100 points. A higher score indicates a greater degree of disability due to the vertiginous symptoms.
Time Frame
at twelve weeks.
Secondary Outcome Measure Information:
Title
CSI (Central Sensitization Inventory)
Description
Evaluates a wide range of somatic and emotional symptoms common to central sensitization syndromes (CSS). The total score of the CSI from 0 to 100. Higher scores indicate greater severity of symptoms.
Time Frame
Baseline
Title
CSI (Central Sensitization Inventory)
Description
Evaluates a wide range of somatic and emotional symptoms common to central sensitization syndromes (CSS). The total score of the CSI from 0 to 100. Higher scores indicate greater severity of symptoms.
Time Frame
at eight weeks
Title
CSI (Central Sensitization Inventory)
Description
Evaluates a wide range of somatic and emotional symptoms common to central sensitization syndromes (CSS). The total score of the CSI from 0 to 100. Higher scores indicate greater severity of symptoms.
Time Frame
at twelve weeks.
Title
PCS (Pain Catastrophizing Scale)
Description
Evaluates the patient's catastrophic thoughts. The total score of the PCS from 0 to 52. Higher scores indicate a greater presence of catastrophic thoughts.
Time Frame
Baseline
Title
PCS (Pain Catastrophizing Scale)
Description
Evaluates the patient's catastrophic thoughts. The total score of the PCS from 0 to 52. Higher scores indicate a greater presence of catastrophic thoughts.
Time Frame
at eight weeks
Title
PCS (Pain Catastrophizing Scale)
Description
Evaluates the patient's catastrophic thoughts. The total score of the PCS from 0 to 52. Higher scores indicate a greater presence of catastrophic thoughts.
Time Frame
at twelve weeks.
Title
TSK (Tampa Scale for Kinesiophobia)
Description
Evaluates fear of movement to injury. The total score of the TSK from 11 to 44 points. Higher scores indicate a greater fear of movement.
Time Frame
Baseline
Title
TSK (Tampa Scale for Kinesiophobia)
Description
Evaluates fear of movement to injury. The total score of the TSK from 11 to 44 points. Higher scores indicate a greater fear of movement.
Time Frame
at eight weeks
Title
TSK (Tampa Scale for Kinesiophobia)
Description
Evaluates fear of movement to injury. The total score of the TSK from 11 to 44 points. Higher scores indicate a greater fear of movement.
Time Frame
at twelve weeks.
Title
VAS-pain (Visual Analogue Scale)
Description
Evaluates the pain on a numerical scale from 0 to 10. Higher scores indicate more pain
Time Frame
Baseline
Title
VAS-pain (Visual Analogue Scale)
Description
Evaluates the pain on a numerical scale from 0 to 10. Higher scores indicate more pain
Time Frame
at eight weeks
Title
VAS-pain (Visual Analogue Scale)
Description
Evaluates the pain on a numerical scale from 0 to 10. Higher scores indicate more pain
Time Frame
at twelve weeks
Title
SF-12 (12-Item Short Form Survey)
Description
Evaluates the impact of health on an individual's everyday life. Used as a quality of life measure.
Time Frame
Baseline
Title
SF-12 (12-Item Short Form Survey)
Description
Evaluates the impact of health on an individual's everyday life. Used as a quality of life measure.
Time Frame
at eight weeks
Title
SF-12 (12-Item Short Form Survey)
Description
Evaluates the impact of health on an individual's everyday life. Used as a quality of life measure.
Time Frame
at twelve weeks
Title
FES-I (Falls Efficacy Scale-International)
Description
Evaluates the fear of falling. The total score of the FES-I from 16 to 64 points. Higher scores indicate greater fear of falling.
Time Frame
Baseline
Title
FES-I (Falls Efficacy Scale-International)
Description
Evaluates the fear of falling. The total score of the FES-I from 16 to 64 points. Higher scores indicate greater fear of falling.
Time Frame
at eight weeks
Title
FES-I (Falls Efficacy Scale-International)
Description
Evaluates the fear of falling. The total score of the FES-I from 16 to 64 points. Higher scores indicate greater fear of falling.
Time Frame
at twelve weeks
Title
FSS (Fatigue Severity Scale)
Description
Evaluates severity of fatigue. Higher scores indicate a greater severity of fatigue
Time Frame
Baseline
Title
FSS (Fatigue Severity Scale)
Description
Evaluates severity of fatigue. Higher scores indicate a greater severity of fatigue
Time Frame
at eight weeks
Title
FSS (Fatigue Severity Scale)
Description
Evaluates severity of fatigue. Higher scores indicate a greater severity of fatigue
Time Frame
at twelve weeks
Title
20-item JAEN screening tool
Description
Evaluates balance and neuromotor function in patients with fibromyalgia. Thd total scale of the Jaen-Screening Tools, from 0 to 80 points. A higher score indicates a greater degree of balance disorder.
Time Frame
Baseline
Title
20-item JAEN screening tool
Description
Evaluates balance and neuromotor function in patients with fibromyalgia. Thd total scale of the Jaen-Screening Tools, from 0 to 80 points. A higher score indicates a greater degree of balance disorder.
Time Frame
at eight weeks
Title
20-item JAEN screening tool
Description
Evaluates balance and neuromotor function in patients with fibromyalgia. Thd total scale of the Jaen-Screening Tools, from 0 to 80 points. A higher score indicates a greater degree of balance disorder.
Time Frame
at twelve weeks
Title
SVV (Subjective Visual Vertical)
Description
Evaluates the perception of verticality, measured using the Subjective Visual Vertical (SVV) test using a virtual reality device.
Time Frame
baseline
Title
SVV (Subjective Visual Vertical)
Description
Evaluates the perception of verticality, measured using the Subjective Visual Vertical (SVV) test using a virtual reality device.
Time Frame
at eight weeks
Title
SVV (Subjective Visual Vertical)
Description
Evaluates the perception of verticality, measured using the Subjective Visual Vertical (SVV) test using a virtual reality device.
Time Frame
at twelve weeks
Title
Stabilometric Platform
Description
Instrument composed of resistive pressure sensors, used to measure the static or postural balance. The test was performed under both eyes-open and eyes-closed conditions.
Time Frame
Baseline
Title
Stabilometric Platform
Description
Instrument composed of resistive pressure sensors, used to measure the static or postural balance. The test was performed under both eyes-open and eyes-closed conditions.
Time Frame
at eight weeks
Title
Stabilometric Platform
Description
Instrument composed of resistive pressure sensors, used to measure the static or postural balance. The test was performed under both eyes-open and eyes-closed conditions.
Time Frame
at twelve weeks
Title
Therapeutic Adherence at home
Description
It assesses adherence to home treatment through a weekly record diary, where patients must record the number of times a day they perform the prescribed exercises, with a range of 0 to 80. Higher scores indicate greater adherence to home treatment. A score of 80 indicates 100% adherence.
Time Frame
Throughout the intervention phase, eight weeks
Title
Satisfaction level
Description
Evaluates the level of satisfaction using a Likert scale, with five response options, from "very dissatisfied" to "very satisfied". The total score of 0-24. A high score indicates greater satisfaction
Time Frame
at eight weeks
Title
GRC (Global Change Rating Scales)
Description
Assesses whether the patient's health status has improved or deteriorated after the treatment received, with ten response options ranging from "the worst it could be" to "the best it could be"
Time Frame
at eight weeks
Other Pre-specified Outcome Measures:
Title
Height (Anthropometrics Data)
Description
Patient height measured in meters (m)
Time Frame
Baseline
Title
Weight (Anthropometrics Data)
Description
Patient's body weight in kilograms (kg)
Time Frame
Baseline
Title
Body Mass Index (Anthropometrics Data)
Description
Weight and height will be combined to report body mass index in kg/m^2
Time Frame
Baseline
Title
Demographics Data
Description
Registration of information provided by the patient on sex, age, education level. occupation and civil status
Time Frame
Baseline

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Aged 18-70 years, Diagnostic for fibromyalgia as described by the 2016 American College of Rheumatology (ACR) Exclusion Criteria: Cognitive impairment impacting ability to fill out the scales and questionnaires. Musculoskeletal surgical intervention in the preceding 6 months and/or acute traumatic pathology to the inferior limb(s). Musculoskeletal disease with deformity of the inferior limbs. Diagnosed with vestibular, visual and/or auditory pathology. Neurologic illness that could be the cause of a balance disorder.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rafael Lomas-Vega, PhD
Organizational Affiliation
University of Jaén
Official's Role
Principal Investigator
Facility Information:
Facility Name
University os Jaén
City
Jaén
ZIP/Postal Code
23071
Country
Spain

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Effectiveness of Vestibular Rehabilitation for Improving Health Status in Patients With Fibromyalgia

We'll reach out to this number within 24 hrs